Acute Psychosis Precipitated by Lacosamide

Gregory A. Sullivan, MD^a,b; Shixie Jiang, MD^a; Christine Whitehead, MD^a

Prim Care Companion CNS Disord 2023;25(1):22cr03302

Free Access: Please Log In

This content is completely free—but you need to be logged in to read the full article. If you already have an account, please log in below. Otherwise, register for free to unlock instant access.

References (8)

Piedad J, Rickards H, Besag FM, et al. Beneficial and adverse psychotropic effects of antiepileptic drugs in patients with epilepsy: a summary of prevalence, underlying mechanisms and data limitations. CNS Drugs. 2012;26(4):319–335. PubMed CrossRef
UCB Pharma Inc. Vimpat (Lacosamide) US Prescribing Information. Smyrna, GA: UCB Pharma Inc.; 2017.
Shrestha PV, Syed A, Marwaha R. Lacosamide-induced tactile hallucinations in a patient with complex partial seizures. J Neuropsychiatry Clin Neurosci. 2014;26(3):E8–E9. PubMed CrossRef
Pinkhasov A, Lam T, Hayes D, et al. Lacosamide induced psychosis: case report, review of differential diagnosis and relevant pharmacokinetics. Clin Neuropharmacol. 2015;38(5):198–200. PubMed CrossRef
Guler S, Dilek S, Inci E, et al. Lacosamide-induced visual hallucinations and psychosis: a case report and literature review. Epilepsi. 2021;27(2):119–122.
Patel A, Noto J, Little D, Carran M. Hallucinations as adverse events from lacosamide: three case series. Neurology. 2018;90(15 suppl);P5.261.
Rees E, Carrera N, Morgan J, et al; GROUP Investigators. Targeted sequencing of 10,198 samples confirms abnormalities in neuronal activity and implicates voltage-gated sodium channels in schizophrenia pathogenesis. Biol Psychiatry. 2019;85(7):554–562. PubMed CrossRef
Nomoto M, Konopaske GT, Yamashita N, et al. Clinical evidence that a dysregulated master neural network modulator may aid in diagnosing schizophrenia. Proc Natl Acad Sci U S A. 2021;118(31):e2100032118. PubMed CrossRef